Crossmark

Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach

Crossref DOI link: https://doi.org/10.1007/s00403-019-02028-2

Published Online: 2019-12-14

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salido-Vallejo, Rafael https://orcid.org/0000-0001-7210-8959
Jiménez-Nájar, F.

Garnacho-Sucedo, G.

Vélez, A.
License Information

Text and Data Mining valid from 2019-12-14

Version of Record valid from 2019-12-14
More Information

Article History

Received: 18 October 2019

Revised: 20 November 2019

Accepted: 7 December 2019

First Online: 14 December 2019

Compliance with ethical standards

:

: Dr. Salido-Vallejo has served as advisor for Almirall, Biofrontera and Leo Pharma and participated in clinical trials for Almirall and Leo Pharma. He has received speaker´s honoraria for Almirall, Biofrontera, Cantabria Labs, Galderma and MEDA. The rest of authors have no conflict of interest.

Document is current

Any future updates will be listed below